Skip to main content

Advertisement

Log in

Psychopathological profile and health-related quality of life (HRQOL) in patients with hepatocellular carcinoma (HCC) and cirrhosis

  • Original Article
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

Abstract

In some tumors, psychosocial interventions may enhance health-related quality of life (HRQOL) of patients. The effects of psychological variables on HRQOL in hepatocellular carcinoma (HCC) patients have been rarely assessed. The aim of this work is to evaluate the psychopathological profile of HCC and cirrhotic patients and its effect on HRQOL. Twenty-four HCC patients (median age 71, Child A 21, Child B 3), 22 cirrhotic patients (median age 68, Child A 20, Child B 2) and 20 control subjects were included in this study. Each subject completes four questionnaires: medical outcomes study short form-36 (SF-36, HRQOL evaluation); Hamilton-D (quantitative evaluation of depression; positive ≥8); symptom check list 90-revised (SCL 90-R, general psychopathological profile; nine domains, each positive >1); Toronto alexithymia scale (TAS 20) (positive ≥60). SCL 90-R: cirrhotic patients differ from HCC subjects for somatization (SOM) (M ± SD 1.09 ± 0.6 vs 0.65 ± 0.6; p = 0.01) and anxiety (M ± SD 0.85 ± 0.46 vs 0.58 ± 0.38; p = 0.01) items. TAS 20: positive in 50 % of HCC patients, in 54 % of cirrhotic patients (p = n.s.) and in none of controls. Hamilton-D: higher scores in cirrhotic patients than in the HCC group (86 vs 46 %; p = 0.005). SF-36: each item, except bodily pain, is lower in both group of patients in comparison with controls. Pearson correlation analysis shows negative correlations on HRQOL of depression, SOM and anxiety both in cirrhotic and HCC subjects, also of obsessive–compulsive and hostility items in HCC. This is the first report on the psychopathological profile of HCC patients: the results open questions on the role of psychological interventions that may improve HRQOL of patients before treatment and in the follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

HRQOL:

Health-related quality of life

HCC:

Hepatocellular carcinoma

SF-36:

Medical outcomes study short form-36

SCL 90-R:

Symptom checklist 90-revised

TAS-20:

Toronto alexithymia scale

EASL:

European association for the study of the liver

BCLC:

Barcelona classification liver cancer

PCS:

Physical component summary

MCS:

Mental component summary

HCV:

Hepatitis C virus

HBV:

Hepatitis B virus

References

  1. McGlynn KA, London WT (2011) The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis 15:223–243

    Article  PubMed  PubMed Central  Google Scholar 

  2. McCracken M, Olsen M, Chen MS Jr, Jemal A, Thun M, Cokkinides V (2007) Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin 57(4):190–205

    Article  PubMed  Google Scholar 

  3. Bedard G, Zeng L, Lam H et al (2012) Meaningful change in oncology quality-of-life instruments: a systematic literature review. Expert Rev Pharmacoecon Outcomes Res 12(4):475–483

    Article  PubMed  Google Scholar 

  4. Nicklasson M, Elfström ML, Olofson J, Bergman B (2013) The impact of individual quality of life assessment on psychosocial attention in patients with chest malignancies: a randomized study. Support Care Cancer 21(1):87–95

    Article  PubMed  Google Scholar 

  5. Rosenbloom SK, Victorson DE, Hahn EA, Peterman AH, Cella D (2007) Assessment is not enough: a randomized controlled trial of the effects of HRQL assessment on quality of life and satisfaction in oncology clinical practice. Psychooncology 16(12):1069–1079

    Article  PubMed  Google Scholar 

  6. Winters ZE, Benson JR, Pusic AL (2010) A systematic review of the clinical evidence to guide treatment recommendations in breast reconstruction based on patient-reported outcome measures and health-related quality of life. Ann Surg 252(6):929–942

    Article  PubMed  Google Scholar 

  7. Paskett E, Herndon J II, Donohue K, Naughton M, Grubbs S, Pavy M (2009) Health-related quality of life in long-term breast cancer survivors: differences by adjuvant chemotherapy dose in cancer and leukemia group B study 8541. Cancer 115(5):1109–1120

    Article  PubMed  PubMed Central  Google Scholar 

  8. European Association For The Study Of The Liver; European Organization For Research And Treatment Of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56(4):908–943

    Article  Google Scholar 

  9. Fan SY, Eiser C, Ho MC, Lin CY (2013) Health-related quality of life in patients with hepatocellular carcinoma: the mediation effects of illness perceptions and coping. Psychooncology 22(6):1353–1360

    Article  PubMed  Google Scholar 

  10. Fan SY, Eiser C, Ho MC (2010) Health-related quality of life in patients with hepatocellular carcinoma: a systematic review. Clin Gastroenterol Hepatol 8(7):559–564

    Article  PubMed  Google Scholar 

  11. Parkash O, Iqbal R, Azam I, Jafri F, Jafri W (2012) Frequency of poor quality of life and predictors of health related quality of life in cirrhosis at a tertiary care hospital Pakistan. BMC Res Notes 5(1):446

    Article  PubMed  PubMed Central  Google Scholar 

  12. Park CL, Gaffey AE (2007) Relationships between psychosocial factors and health behavior change in cancer survivors: an integrative review. Ann Behav Med 34(2):115–134

    Article  PubMed  Google Scholar 

  13. Pugliese P, Perrone M, Nisi E et al (2006) An integrated psychological strategy for advanced colorectal cancer patients. Health Qual Life Outcomes 6:4–9

    Google Scholar 

  14. Derogatis LR (1983) Symptom checklist-90-R administration, scoring and procedures manual II. Clinical Psychometric Research, Towson, MD, pp 14–15

    Google Scholar 

  15. Potts MK, Daniels M, Burnam MA, Wells KB (1990) A structured interview version of the Hamilton Depression Rating Scale: evidence of reliability and versatility of administration. J Psychiatr Res 24(4):335–350

    Article  CAS  PubMed  Google Scholar 

  16. Bagby RM, Parker JDA, Taylor GJ (1994) The twenty-item Toronto Alexithymia Scale—I. Item selection and cross validation of the factor structure. J Psychosom Res 38(1):23–32

    Article  CAS  PubMed  Google Scholar 

  17. Todarello O, Porcelli P, Costrutto di alexithymia I, Todarello O, Porcelli P (eds) (2002) Medicina psicosomatica. Valutazione scientifica, integrazione organizzativa e costo sociale. Franco Angeli, Milano, pp 97–149

    Google Scholar 

  18. Llovet JM, Di Bisceglie AM, Bruix J et al (2008) Design and endpoints of clinical trials in hepatocellular carcinoma. JNCI J Natl Cancer Inst 100(10):698–711

    Article  PubMed  Google Scholar 

  19. Apolone G, Mosconi P (1998) The Italian SF-36 health survey: translation, validation and norming. J Clin Epidemiol 51(11):1025–1036

    Article  CAS  PubMed  Google Scholar 

  20. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD (1994) The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32(1):40–66

    Article  CAS  PubMed  Google Scholar 

  21. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23(1):56–62

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Guy W (1976) ECDEU assessment manual for psychopharmacology. National Institute of Mental Health (U.S.). Psychopharmacology Research Branch; Early Clinical Drug Evaluation Program. (Ed). Rockville, Md. : U. S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs

  23. Derogatis LR (2000) Symptom Checklist-90-Revised. Handbook of Psychiatric Measures Arlington, VA: American Psychiatric Association 40(10): 81–84

  24. Taylor GJ, Ryan D, Bagby RM (1985) Toward the development of a new self-report alexithymia scale. Psychother Psychosom 44(4):191–199

    Article  CAS  PubMed  Google Scholar 

  25. Breitbart W, Poppito S, Rosenfeld B et al (2012) Pilot randomized controlled trial of individual meaning-centered psychotherapy for patients with advanced cancer. J Clin Oncol 30(12):1304–1309

    Article  PubMed  PubMed Central  Google Scholar 

  26. Johns SA, Kroenke K, Krebs EE, Theobald DE, Wu J, Tu W (2013) Longitudinal comparison of three depression measures in adult cancer patients. J Pain Symptom Manage 45(1):71–82

    Article  PubMed  PubMed Central  Google Scholar 

  27. López-Navas A, Ríos A, Moya-Faz FG et al (2012) Emotional-type psychopathologic symptoms among patients with terminal chronic alcohol-induced liver cirrhosis. Transplant Proc 44:1510–1512

    Article  PubMed  Google Scholar 

  28. Nardelli S, Pentassuglio I, Pasquale C et al (2013) Depression, anxiety and alexithymia symptoms are major determinants of health related quality of life (HRQOL) in cirrhotic patients. Metab Brain Dis 28(2):239–243

    Google Scholar 

  29. Di Matteo MR, Di Nicola DD (1982) Achieving patient compliance. Pergamon Press Inc, New York. Elmsford

    Google Scholar 

  30. Wong WS, Fielding R (2008) The association between patient satisfaction and quality of life in Chinese lung and liver cancer patients. Med Care 46(3):293–302

    Article  PubMed  Google Scholar 

  31. Kondo Y, Yoshida H, Tateishi R et al (2007) Health-related quality of life of chronic liver disease patients with and without hepatocellular carcinoma. J Gastroenterol Hepatol 22:197–203

    Article  PubMed  Google Scholar 

  32. Loria A, Escheik C, Gerber NL, Younossi ZM (2013) Quality of life in cirrhosis. Curr Gastroenterol Rep 15:301–305

    Article  PubMed  Google Scholar 

  33. Marchesini G, Bianchi G, Amodio P et al (2001) Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 120:170–178

    Article  CAS  PubMed  Google Scholar 

  34. Arguedas MR, DeLawrence TG, McGuire BM (2003) Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci 48(8):1622–1626

    Article  PubMed  Google Scholar 

  35. Afendy A, Kallman JB, Stepanova M et al (2009) Predictors of health-related quality of life in patients with chronic liver disease. Aliment Pharmacol Ther 30:469–476

    Article  CAS  PubMed  Google Scholar 

  36. Han D, Zhang Y, Li B et al (2012) Alexithymia in Chinese chronic obstructive pulmonary disease (COPD) patients: The prevalence and related factors of alexithymia. Psychiatry Res 198:274–278

    Article  PubMed  Google Scholar 

  37. Hyphantis T, Paika V, Almyroudi A, Kampletsas EO, Pavlidis N (2011) Personality variables as predictors of early non-metastatic colorectal cancer patients’ psychological distress and health related quality of life: a one-year prospective study. J Psychosom Res 70(5):411–421

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by a research fund of the University of Bari, and it has been accepted as a poster presentation at the 47th Meeting of European Association Study Liver, Barcelona, 9–12 April, 2012.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vincenzo O. Palmieri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Palmieri, V.O., Santovito, D., Margari, F. et al. Psychopathological profile and health-related quality of life (HRQOL) in patients with hepatocellular carcinoma (HCC) and cirrhosis. Clin Exp Med 15, 65–72 (2015). https://doi.org/10.1007/s10238-013-0267-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-013-0267-0

Keywords

Navigation